Royalty Pharma plc
RPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $939 | $632 | $1,088 | $929 |
| Short-Term Investments | $16 | $856 | $729 | $842 |
| Receivables | $889 | $28 | $24 | $27 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $3 | $4 |
| Total Curr. Assets | $1,850 | $1,520 | $1,843 | $1,802 |
| Property Plant & Equip (Net) | $20 | $0 | $0 | $0 |
| Goodwill | $925 | $925 | $0 | $0 |
| Intangibles | $5 | $0 | $0 | $0 |
| Long-Term Investments | $723 | $15,793 | $15,728 | $16,387 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15,825 | $85 | $37 | $34 |
| Total NC Assets | $17,498 | $16,803 | $15,765 | $16,421 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,347 | $18,323 | $17,608 | $18,223 |
| Liabilities | – | – | – | – |
| Payables | $41 | $20 | $38 | $13 |
| Short-Term Debt | $383 | $999 | $999 | $998 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $106 | $187 | $147 | $242 |
| Total Curr. Liab. | $531 | $1,207 | $1,183 | $1,254 |
| LT Debt | $8,583 | $7,003 | $6,619 | $6,615 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $613 | $610 | $18 | $12 |
| Total NC Liab. | $9,196 | $7,614 | $6,637 | $6,627 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $20 | $0 | $0 | $0 |
| Total Liabilities | $9,726 | $8,820 | $7,820 | $7,880 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $2,304 | $2,223 | $2,481 | $2,846 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $4,110 | $4,125 | $4,208 | $4,101 |
| Total Equity | $6,414 | $6,348 | $6,689 | $6,947 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $3,207 | $3,155 | $3,100 | $3,396 |
| Total Liab. & Tot. Equity | $19,347 | $18,323 | $17,608 | $18,223 |
| Net Debt | $8,027 | $7,371 | $6,530 | $6,683 |